SCHEMBL22607329

SCHEMBL22607329

CC(=O)NC(C)C(=O)NC(CCC(=O)NC(CCCCNC(=O)CCC(=O)O)C(N)=O)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SIRT5 Q9NXA8 4/20 0.54
▸ ALB P02768 2/20 0.47
▸ NOD1 Q9Y239 1/20 0.47
▸ ESR1 P03372 1/20 0.47
▸ PGR P06401 1/20 0.47
▸ HTR1A P08908 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47
▸ AR P10275 1/20 0.47
▸ CHRM1 P11229 1/20 0.47
▸ TBXA2R P21731 1/20 0.47
▸ PTGS1 P23219 1/20 0.47
▸ ADRA1A P35348 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ SIRT2 Q8IXJ6 1/20 0.47
▸ FOLH1 Q04609 1/20 0.44
▸ GLP1R P43220 8/20 0.41
▸ TLR2 O60603 1/20 0.40
▸ GNPAT O15228 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800100 0.86 SIRT5 (0.62) SIRT5ALBNOD1CHRM1ADRA1A
SCHEMBL10778212 0.81 NOD1 (0.59) SIRT5NOD1ESR1PGRHTR1A
SCHEMBL11596384 0.80 NOD2 (0.49) SIRT5NOD1SIRT2FOLH1GNPAT
SCHEMBL17424382 0.79 SIRT5 (0.55) SIRT5ALBNOD1SIRT2FOLH1
SCHEMBL12035334 0.79 SIRT5 (0.55) SIRT5SIRT2FOLH1
SCHEMBL29430995 0.78 NOD1 (0.51) SIRT5NOD1ESR1PGRHTR1A
SCHEMBL17359223 0.77 ALB (0.52) SIRT5ALBNOD1FOLH1GLP1R
SCHEMBL14685805 0.77 ALB (0.52) SIRT5ALBNOD1FOLH1GLP1R
SCHEMBL10653624 0.77 ESR1 (0.57) NOD1ESR1PGRHTR1AADORA3
SCHEMBL13214020 0.76 ALB (0.51) SIRT5ALBNOD1FOLH1GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3239139-B1 CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE NINGBO COMBIREG PHARMACEUTICAL TECH CO LTD (CN) 2020-10-28 — — EP disclosed
Send feedback